# The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients

> **NCT01974336** · PHASE4 · COMPLETED · sponsor: **Jinling Hospital, China** · enrollment: 30 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** ursodeoxycholic acid

## Key facts

- **NCT ID:** NCT01974336
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2016-04
- **Final completion:** 2016-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01974336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01974336, "The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01974336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*